Behavioral phenotyping of glutathione-deficient mice: Relevance to schizophrenia and bipolar disorder
Abstract
Redox-dysregulation represents a common pathogenic mechanism in schizophrenia (SZ) and bipolar disorder (BP). It may in part arise from a genetically compromised synthesis of glutathione (GSH), the major cellular antioxidant and redox-regulator. Allelic variants of the genes coding for the rate-limiting GSH synthesizing enzyme glutamate-cysteine-ligase modifier (GCLM) and/or catalytic (GCLC) subunit have been associated with SZ and BP. Using mice knockout (KO) for GCLM we have previously shown that impaired GSH synthesis is associated with morphological, functional and neurochemical anomalies similar to those in patients. Here we asked whether GSH deficit is also associated with SZ- and BP-relevant behavioral and cognitive anomalies. Accordingly, we subjected young adult GCLM-wildtype (WT), heterozygous and KO males to a battery of standard tests. Compared to WT, GCLM-KO mice displayed hyperlocomotion in the open field and forced swim test but normal activity in the home cage, suggesting that hyperlocomotion was selective to environmental novelty and mildly stressful situations. While spatial working memory and latent inhibition remained unaffected, KO mice showed a potentiated hyperlocomotor response to an acute amphetamine injection, impaired sensorymotor gating in the form of prepulse inhibition and altered social behavior compared to WT. These anomalies resemble important aspects of both SZ and the manic component of BP. As such our data support the notion that redox-dysregulation due to GSH deficit is implicated in both disorders. Moreover, our data propose the GCLM-KO mouse as a valuable model to study the behavioral and cognitive consequences of redox dysregulation in the context of psychiatric disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Transient pharmacological depletion of brain GSH early in development (between postnatal days 5 and 16) leads to PVI abnormalities in the adult anterior cingulate cortex as well as cognitive and olfactory discrimination deficits.
“Moreover, transient pharmacological depletion of brain GSH early in development (between postnatal days 5 and 16) leads to PVI abnormalities in the adult anterior cingulate cortex as well as cognitive and olfactory discrimination deficits 49 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [49]
Pharmacological depletion of brain GSH using a GCL inhibitor induces sensory and cognitive disturbances similar to schizophrenia.
“Pharmacological depletion of brain GSH using a GCL inhibitor induces similar sensory and cognitive disturbances 48,49 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [49]
Cites
Behavioural despair in rats: A new model sensitive to antidepressant treatments
Porsolt, R. D., Anton, G., Blavet, N., & Jalfre, M. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90118-8 · Cited by 3,138 · see citing works
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · see citing works
Floresco, S. B., West, A. R., Ash, B., Moore, H., & Grace, A. A. (2003) · Nature Neuroscience · doi:10.1038/nn1103 · Cited by 1,106 · see citing works
Mesocorticolimbic dopaminergic network: functional and regulatory roles
Moal, M. L., & Simon, H. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.155 · Cited by 1,096 · see citing works
Mania-like behavior induced by disruption of <i>CLOCK</i>
Roybal, K., Theobold, D., Graham, A., DiNieri, J. A., Russo, S. J., Krishnan, V., Chakravarty, S., Peevey, J., Oehrlein, N., Birnbaum, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609625104 · Cited by 803 · see citing works
A review of diffusion tensor imaging studies in schizophrenia
Kubicki, M., McCarley, R., Westin, C.-F., Park, H.-J., Maier, S., Kikinis, R., Jolesz, F. A., & Shenton, M. E. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.05.005 · Cited by 769 · see citing works
Sex differences in schizophrenia
Abel, K. M., Drake, R., & Goldstein, J. M. (2010) · International Review of Psychiatry · doi:10.3109/09540261.2010.515205 · Cited by 762 · see citing works
Increased dopamine transmission in schizophrenia: relationship to illness phases.
Laruelle, M., Abi-Dargham, A., Gil, R. B., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 744 · see citing works
Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimers Disease
Agostinho, P., A. Cunha, R., & Oliveira, C. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793176572 · Cited by 685 · see citing works
Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia
Walker, E., Mittal, V., & Tessner, K. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.4.022007.141248 · Cited by 615 · see citing works
Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594 · see citing works
Anatomy of bipolar disorder and schizophrenia: A meta-analysis
Ellison-Wright, I., & Bullmore, E. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.022 · Cited by 565 · see citing works
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · see citing works
Self-citationProvocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 535 · see citing works
Oxidative stress markers in bipolar disorder: A meta-analysis
Andreazza, A. C., Kauer-Sant'Anna, M., Frey, B. N., Bond, D. J., Kapczinski, F., Young, L. T., & Yatham, L. N. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.04.013 · Cited by 526 · see citing works
The phenomenology of experimentally induced amphetamine psychosis--preliminary observations.
ANGRIST, B. M., & Gershon, S. (1970) · PubMed · Cited by 477 · see citing works
Oxidative stress in schizophrenia: An integrated approach
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.008 · Cited by 474 · see citing works
Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis
Arnone, D., Cavanagh, J., Gerber, D., Lawrie, S. M., Ebmeier, K. P., & McIntosh, A. M. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.059717 · Cited by 441 · see citing works
Redox dysregulation, neurodevelopment, and schizophrenia
Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.05.001 · Cited by 384 · see citing works
The Experimental Reproduction of Amphetamine Psychosis
Bell, D. S. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200010020003 · Cited by 355 · see citing works
Cadenhead, K. S., Swerdlow, N. R., Shafer, K. M., Díaz, M. M., & BRAFF, D. L. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1660 · Cited by 354 · see citing works
Is sex important? Gender differences in bipolar disorder
Diflorio, A., & Jones, I. (2010) · International Review of Psychiatry · doi:10.3109/09540261.2010.514601 · Cited by 330 · see citing works
Altered glutathione redox state in schizophrenia.
Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321 · see citing works
The Society for Neuroscience 1995 annual meeting.
Hu, R. J. (1996) · PubMed · Cited by 313 · see citing works
Cognitive functioning in patients with schizophrenia and bipolar disorder: A quantitative review
A, L. K. M., Arts, B. M. G., van Os, J., & Aleman, A. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.004 · Cited by 312 · see citing works
Information-processing deficits and thought disorder in schizophrenia
Perry, W., & BRAFF, D. L. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.363 · Cited by 311 · see citing works
Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence
Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., Deppen, P., Preisig, M., Ruiz, V., Steullet, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706778104 · Cited by 309 · see citing works
Mouse genetic models for prepulse inhibition: an early review
Geyer, M. A., McIlwain, K. L., & Paylor, R. E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001159 · Cited by 289 · see citing works
Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
Yao, J. K., & Keshavan, M. S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3603 · Cited by 285 · see citing works
Impaired Recognition of Facial Emotion in Mania
Lembke, A., & Ketter, T. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.302 · Cited by 281 · see citing works
Theory of mind deficits in bipolar affective disorder
Kerr, N. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00008-3 · Cited by 279 · see citing works
Initial Characterization of the Glutamate-Cysteine Ligase Modifier Subunit Gclm(−/−) Knockout Mouse
Yang, Y., Dieter, M. Z., Chen, Y., Shertzer, H. G., Nebert, D. W., & Dalton, T. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209372200 · Cited by 269 · see citing works
Hippocampal modulation of sensorimotor processes.
Bast, T., & Feldon, J. (2003) · Progress in neurobiology · doi:10.1016/s0301-0082(03)00112-6 · Cited by 267 · see citing works
15th annual meeting of the society for neuroscience
(1985) · Peptides · doi:10.1016/0196-9781(85)90125-1 · Cited by 240 · see citing works
Perry, W., Geyer, M. A., & BRAFF, D. L. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.3.277 · Cited by 238 · see citing works
Role of the ventral subiculum in stress integration
Herman, J. P., & Mueller, N. K. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.05.035 · Cited by 235 · see citing works
Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene
Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.-L., Parnas, J., Preisig, M., Saraga, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/507566 · Cited by 234 · see citing works
A role for white matter abnormalities in the pathophysiology of bipolar disorder
Mahon, K., Burdick, K. E., & Szeszko, P. R. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.10.012 · Cited by 227 · see citing works
Reversal of Oxidative Stress-Induced Anxiety by Inhibition of Phosphodiesterase-2 in Mice
Masood, A., Nadeem, A., Mustafa, S. J., & O’Donnell, J. M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137208 · Cited by 225 · see citing works
The Neurobiology of the Switch Process in Bipolar Disorder
Salvadore, G., Quiroz, J. A., Machado‐Vieira, R., Henter, I. D., Manji, H. K., & Zarate, C. A. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05259gre · Cited by 210 · see citing works
Neurophysiological Endophenotypes Across Bipolar and Schizophrenia Psychosis
Thaker, G. K. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn049 · Cited by 203 · see citing works
Steullet, P., Cabungcal, J.-H., Kulak, A., Kraftsik, R., Chen, Y., Dalton, T. P., Cuenod, M., & Do, K. Q. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3857-09.2010 · Cited by 202 · see citing works
Self-citationMatsuzawa, D., Obata, T., Shirayama, Y., Nonaka, H., Kanazawa, Y., Yoshitome, E., Takanashi, J., Matsuda, T., Shimizu, E., Ikehira, H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001944 · Cited by 201 · see citing works
Raffa, M., Mechri, A., Othman, L. B., Fendri, C., Gaha, L., & Kerkeni, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.018 · Cited by 173 · see citing works
Shaltiel, G., Maeng, S., Malkesman, O., Pearson, B., Schloesser, R. J., Tragon, T., Rogawski, M., Gasior, M., Luckenbaugh, D., Chen, G., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.20 · Cited by 173 · see citing works
Abdalla, D. S. P., Monteiro, H., Oliveira, J., & Bechara, E. J. H. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.5.805 · Cited by 168 · see citing works
Parkinson's disease: insights from pathways
Cookson, M., & Bandmann, O. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq167 · Cited by 162 · see citing works
Schizophrenia and bipolar disorder: differences and overlaps
Maier, W., Zobel, A., & Wagner, M. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000214342.52249.82 · Cited by 156 · see citing works
O’Tuathaigh, C. M. P., Babovic, D., O’Meara, G. F., Clifford, J. J., Croke, D. T., & Waddington, J. L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.04.002 · Cited by 151 · see citing works
Ikemoto, S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00247-6 · Cited by 134 · see citing works
Abnormal age-related changes of plasma antioxidant proteins in schizophrenia
Yao, J. K., Reddy, R. D., & van Kammen, D. P. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00230-4 · Cited by 133 · see citing works
Role of oxidative stress in the pathophysiology of bipolar disorder
Steckert, A. V., Valvassori, S. S., Moretti, M., Dal‐Pizzol, F., & Quevedo, J. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0195-2 · Cited by 125 · see citing works
das Neves Duarte, J. M., Kulak, A., Gholam-Razaee, M. M., Cuenod, M., Gruetter, R., & Do, K. Q. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.035 · Cited by 124 · see citing works
Self-citationNeurocognitive allied phenotypes for schizophrenia and bipolar disorder
Hill, S. K., Harris, M. S. H., Herbener, E. S., Pavuluri, M., & Sweeney, J. A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn027 · Cited by 123 · see citing works
Reduced level of plasma antioxidant uric acid in schizophrenia
Yao, J. K., Reddy, R. D., & van Kammen, D. P. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00051-1 · Cited by 121 · see citing works
Bipolar Disorder, Schizoaffective Disorder, and Schizophrenia Overlap
Laursen, T. M., Agerbo, E., & Pedersen, C. B. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04807 · Cited by 121 · see citing works
Young, J. W., van Enkhuizen, J., Winstanley, C. A., & Geyer, M. A. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111400646 · Cited by 114 · see citing works
Frey, B. N., Martins, M. R., Petronilho, F. C., Dal‐Pizzol, F., Quevedo, J., & Kapczinski, F. P. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00318.x · Cited by 109 · see citing works
Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis
Michel, T. M., Thome, J., Martin, D., Keinosuke, N. A. R. A., Zwerina, S., Tatschner, T., Weijers, H. ‐., & Koutsilieri, E. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0160-9 · Cited by 89 · see citing works
Cabungcal, J.-H., Preissmann, D., Delseth, C., Cuénod, M., Kim, Q., & Schenk, F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.001 · Cited by 83 · see citing works
Pantazopoulos, H., LANGE, N. D., Baldessarini, R. J., & Berretta, S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.026 · Cited by 81 · see citing works
Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice
Dean, O. M., Bush, A. I., Berk, M., Copolov, D., & van den Buuse, M. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.017 · Cited by 81 · see citing works
Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia
Matsuzawa, D., & Hashimoto, K. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3453 · Cited by 79 · see citing works
Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder?
Fitzgerald, P. J., Barkus, C., Feyder, M. J., Wiedholz, L. M., Chen, Y.-C., Karlsson, R., Machado‐Vieira, R., Graybeal, C., Sharp, T., Zarate, C. A., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.005 · Cited by 79 · see citing works
Neurobiological trait abnormalities in bipolar disorder
Langan, C., & McDonald, C. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.39 · Cited by 77 · see citing works
Yao, J. K., Dougherty, G. G., Reddy, R. D., Keshavan, M. S., Montrose, D. M., Matson, W. R., McEvoy, J. P., & Kaddurah‐Daouk, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009508 · Cited by 73 · see citing works
Evidence of Disrupted Prepulse Inhibition in Unaffected Siblings of Bipolar Disorder Patients
Giakoumaki, S. G., Roussos, P., Rogdaki, M., Karli, C., Bitsios, P., & Frangou, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.002 · Cited by 72 · see citing works
Vitamin C status in chronic schizophrenia
Subotičanec, K., Folnegović-Šmalc, V., Korbar, M., Mestrovic, B., & Buzina, R. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90061-6 · Cited by 71 · see citing works
Al-chalabi, B. M., Thanoon, I. A. J., & Ahmed, F. A. (2009) · Neuropsychobiology · doi:10.1159/000202823 · Cited by 66 · see citing works
Choy, K. H. C., Dean, O. M., Berk, M., Bush, A. I., & van den Buuse, M. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.035 · Cited by 62 · see citing works
Mamiya, T., Kise, M., & Morikawa, K. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.10.029 · Cited by 61 · see citing works
Genetic causality in schizophrenia and bipolar disorder: out with the old and in with the new
Porteous, D. J. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.07.005 · Cited by 60 · see citing works
Bast, T., Zhang, W.-N., Heidbreder, C. A., & Feldon, J. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00589-3 · Cited by 58 · see citing works
Ackermann, T. F., Kempe, D. S., Lang, F. J. W., & Lang, U. E. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315097 · Cited by 58 · see citing works
Prepulse inhibition in rats with temporary inhibition/inactivation of ventral or dorsal hippocampus
Zhang, W.-N., Bast, T., & Feldon, J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00936-x · Cited by 56 · see citing works
Gogos, A., van den Buuse, M., & Rossell, S. L. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000480 · Cited by 56 · see citing works
Wingo, A. P., & Ghaemi, S. N. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4104 · Cited by 55 · see citing works
Decreased Plasma Antioxidants in Schizophrenia
Pae, C., Paik, I., Lee, C., Lee, S.-J., Kim, J.-J., & Lee, C. (2004) · Neuropsychobiology · doi:10.1159/000077942 · Cited by 52 · see citing works
Castagné, V., Cuénod, M., & Do, K. Q. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.11.012 · Cited by 50 · see citing works
Self-citationCommon risk genes for affective and schizophrenic psychoses
Maier, W. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-2008-z · Cited by 44 · see citing works
Mitochondrial matters of the brain: the role in Huntington’s disease
Turner, C., & Schapira, A. H. V. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-010-9290-y · Cited by 44 · see citing works
Monoaminergic dysregulation in glutathione-deficient mice: Possible relevance to schizophrenia?
Jacobsen, J. P. R., Rodriguiz, R. M., Mørk, A., & Wetsel, W. C. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.059 · Cited by 41 · see citing works
Methods for depleting brain glutathione
Masukawa, T., Sai, M., & Tochino, Y. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90266-x · Cited by 41 · see citing works
Amphetamine and Other Non-opioid Drug Users Attending a Special Drug Dependence Clinic
Gardner, R., & Connell, P. H. (1972) · BMJ · doi:10.1136/bmj.2.5809.322 · Cited by 40 · see citing works
Regulation of sensorimotor gating in rats by hippocampal NMDA: anatomical localization
Swerdlow, N. R., Hanlon, F. M., Henning, L., Kim, Y. K., Gaudet, I., & Halim, N. D. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02143-6 · Cited by 40 · see citing works
Steullet, P., Lavoie, S., Kraftsik, R., Guidi, R., Gysin, R., Cuenod, M., & Do, K. (2008) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2007.12.006 · Cited by 29 · see citing works
Oxidative stress and superoxide dismutase in schizophrenia
Khan, N., & Das, I. (1997) · Biochemical Society Transactions · doi:10.1042/bst025418s · Cited by 29 · see citing works
Cole, T. B., Giordano, G., Co, A. L., Mohar, I., Kavanagh, T. J., & Costa, L. G. (2011) · Journal of Toxicology · doi:10.1155/2011/157687 · Cited by 27 · see citing works
Murphy, C. A., Iorio, L. D., & Feldon, J. (2001) · Psychopharmacology · doi:10.1007/s002130100759 · Cited by 27 · see citing works
de Bruin, N. M. W. J., Mahieu, M., Patel, T., Willems, R., Lesage, A., & Megens, A. A. H. P. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.05.002 · Cited by 18 · see citing works
Loven, D. P., James, J. F., Biggs, L., & Little, K. Y. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00669-9 · Cited by 18 · see citing works
Flagged first, then by citations
1 of the 92 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The promise of N-acetylcysteine in neuropsychiatry
Berk, M., Malhi, G. S., Gray, L. J., & Dean, O. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.001 · Cited by 434 · see citing works
Javitt, D. C., Zukin, S. R., Heresco-Levy, U., & Umbricht, D. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs069 · Cited by 322 · see citing works
Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304 · see citing works
Steullet, P., Cabungcal, J. H., Monin, A., Dwir, D., O'Donnell, P., Cuenod, M., & Do, K. Q. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.021 · Cited by 262 · see citing works
Self-citationInflammation in schizophrenia: A question of balance
Leza, J. C., García‐Bueno, B., Bioque, M., Arango, C., Parellada, M., Kim, Q., O’Donnell, P., & Bernardo, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.014 · Cited by 183 · see citing works
Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia
Maas, D. A., Vallès, A., & Martens, G. J. M. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.138 · Cited by 181 · see citing works
Oxidative stress and schizophrenia
Emiliani, F. E., Sedlak, T. W., & Sawa, A. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000054 · Cited by 168 · see citing works
Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia
Zhang, Y., Hodgson, N., Trivedi, M. S., Abdolmaleky, H. M., Fournier, M., Cuénod, M., Kim, Q., & Deth, R. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146797 · Cited by 164 · see citing works
Do, K. Q., Cuenod, M., & Hensch, T. K. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv065 · Cited by 158 · see citing works
The glutathione cycle shapes synaptic glutamate activity
Sedlak, T., Paul, B., Parker, G. M., Hester, L., Snowman, A., Taniguchi, Y., Kamiya, A., Snyder, S., & Sawa, A. (2018) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1817885116 · Cited by 141 · see citing works
Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders
Murray, A., Rogers, J. C., Katshu, M. Z. U. H., Liddle, P. F., & Upthegrove, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.703452 · Cited by 147 · see citing works
Dwir, D., Giangreco, B., Xin, L., Tenenbaum, L., Cabungcal, J.-H., Steullet, P., Goupil, A., Cleusix, M., Jenni, R., Chtarto, A., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0393-5 · Cited by 137 · see citing works
Animal models of bipolar mania: The past, present and future
Logan, R. W., & McClung, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.041 · Cited by 136 · see citing works
Kulak, A., Steullet, P., Cabungcal, J.-H., Werge, T., Ingason, A., Cuenod, M., & Do, K. Q. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4858 · Cited by 124 · see citing works
Self-citationMonte, A. S., de Souza, G. C., McIntyre, R. S., Soczynska, J. K., Santos, J. V. D., Cordeiro, R. C., Ribeiro, B. M. M., de Lucena, D. F., Vasconcelos, S. M. M., de Sousa, F. C. F., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113503506 · Cited by 124 · see citing works
Monin, A., Baumann, P. S., Griffa, A., Xin, L., Mekle, R., Fournier, M., Butticaz, C., Klaey, M., Cabungcal, J. H., Steullet, P., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.88 · Cited by 113 · see citing works
Self-citationDoes Vitamin C Deficiency Affect Cognitive Development and Function?
Hansen, S. L., Tveden‐Nyborg, P., & Lykkesfeldt, J. (2014) · Nutrients · doi:10.3390/nu6093818 · Cited by 105 · see citing works
Potential Roles of Redox Dysregulation in the Development of Schizophrenia
Perkins, D. O., Jeffries, C. D., & Do, K. Q. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.016 · Cited by 103 · see citing works
Tsugawa, S., Noda, Y., Tarumi, R., Mimura, Y., Yoshida, K., Iwata, Y., ElSalhy, M., Kuromiya, M., Kurose, S., Masuda, F., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119845820 · Cited by 99 · see citing works
Molecular substrates of schizophrenia: homeostatic signaling to connectivity
Landek‐Salgado, M. A., Faust, T. E., & Sawa, A. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.141 · Cited by 93 · see citing works
Vasconcelos, G. S., Ximenes, N. C., de Sousa, C. N. S., Oliveira, T. D. Q., Lima, L. L. L., de Lucena, D. F., Gama, C. S., Macêdo, D. S., & Vasconcelos, S. M. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.04.017 · Cited by 89 · see citing works
Jiang, Z., Cowell, R. M., & Nakazawa, K. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00116 · Cited by 89 · see citing works
Dysfunction of ventral tegmental area GABA neurons causes mania-like behavior
Yu, X., Ba, W., Zhao, G., Ma, Y., Harding, E. C., Yin, L., Wang, D., Li, H., Zhang, P., Shi, Y., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0810-9 · Cited by 62 · see citing works
MicroRNA-155 deletion reduces anxiety- and depressive-like behaviors in mice
Fonken, L. K., Gaudet, A. D., Gaier, K. R., Nelson, R. J., & Popovich, P. G. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.10.019 · Cited by 53 · see citing works
Behavioral Tasks Evaluating Schizophrenia-like Symptoms in Animal Models: A Recent Update
Ang, M. J., Lee, S., Kim, J.-C., Kim, S., & Moon, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200814175114 · Cited by 51 · see citing works
Fernández-Fernández, S., Bobo-Jiménez, V., Requejo-Aguilar, R., Gónzalez-Fernández, S., Resch-Beusher, M., Carabias-Carrasco, M., Ros, J., Almeida, Á., & Bolaños, J. P. (2018) · Redox Biology · doi:10.1016/j.redox.2018.08.003 · Cited by 46 · see citing works
Onaolapo, O. J., Ademakinwa, O. Q., Olalekan, T. O., & Onaolapo, A. Y. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4666-x · Cited by 45 · see citing works
Filho, A. J. M. C., Cunha, N. L., de Souza, A. G., Soares, M. V.-R., Jucá, P. M., de Queiroz, T., Oliveira, J. V. S., Valvassori, S. S., Barichello, T., Quevedo, J., et al. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109872 · Cited by 44 · see citing works
Zhu, X., Cabungcal, J.-H., Cuénod, M., Uliana, D. L., Kim, Q., & Grace, A. A. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01198-8 · Cited by 44 · see citing works
Dwir, D., Cabungcal, J.-H., Xin, L., Giangreco, B., Parietti, E., Cleusix, M., Jenni, R., Klauser, P., Conus, P., Cuénod, M., et al. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab066 · Cited by 40 · see citing works
Baumann, P., Griffa, A., Fournier, M., Golay, P., Ferrari, C., Alameda, L., Cuénod, M., Thiran, J., Hagmann, P., Do, K. Q., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.117 · Cited by 39 · see citing works
Self-citationCoughlin, J. M., Hayes, L. N., Tanaka, T., Xiao, M.-F., Yolken, R. H., Worley, P. F., Leweke, F. M., & Sawa, A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.10.040 · Cited by 38 · see citing works
Omata, Y., Salvador, G. A., Supasai, S., Keenan, A. H., & Oteiza, P. I. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft022 · Cited by 39 · see citing works
Echo time optimization for J‐difference editing of glutathione at 3T
Chan, K. L., Puts, N. A. J., Snoussi, K., Harris, A. D., Barker, P. B., & Edden, R. A. E. (2016) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26122 · Cited by 37 · see citing works
Xia, L., Deloménie, C., Mendez‐David, I., Rainer, Q., Marouard, M., Delacroix, H., David, D. J. P., Gardier, A. M., & Guilloux, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.05.046 · Cited by 36 · see citing works
Górny, M., Bilska‐Wilkosz, A., Iciek, M., Hereta, M., Kamińska, K., Kamińska, A., Chwatko, G., Rogóż, Z., & Lorenc‐Koci, E. (2020) · Antioxidants · doi:10.3390/antiox9060538 · Cited by 35 · see citing works
Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia
Ballesteros, A., Summerfelt, A., Du, X., Jiang, P., Chiappelli, J., Tagamets, M., O’Donnell, P., Kochunov, P., & Hong, L. E. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.05.021 · Cited by 34 · see citing works
Monte, A. S., da Silva, F. E. R., Lima, C. N. D. C., Vasconcelos, G. S., Gomes, N. S., Miyajima, F., Vasconcelos, S. M. M., Gama, C. S., Seeman, M. V., de Lucena, D. F., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119875979 · Cited by 34 · see citing works
van Enkhuizen, J., Geyer, M. A., Minassian, A., Perry, W., Henry, B. L., & Young, J. W. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.008 · Cited by 31 · see citing works
Rosa, J. M., Dafré, A. L., & Rodrigues, A. L. S. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.07.009 · Cited by 32 · see citing works
Neuronal activity induces glutathione metabolism gene expression in astrocytes
McGann, J. C., & Mandel, G. (2018) · Glia · doi:10.1002/glia.23455 · Cited by 29 · see citing works
Toriumi, K., Berto, S., Koike, S., Usui, N., Dan, T., Suzuki, K., Miyashita, M., Horiuchi, Y., Yoshikawa, A., Asakura, M., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102057 · Cited by 31 · see citing works
Borella, V., Seeman, M. V., Cordeiro, R. C., Santos, J. V. D., de Souza, M. R. M., Fernandes, E. N. D. S., Monte, A. S., Vasconcelos, S. M. M., Quinn, J. P., de Lucena, D. F., et al. (2015) · Developmental Neurobiology · doi:10.1002/dneu.22329 · Cited by 31 · see citing works
Early Life and Oxidative Stress in Psychiatric Disorders: What Can we Learn From Animal Models?
Mhillaj, E., Morgese, M. G., & Trabace, L. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150105122422 · Cited by 31 · see citing works
Gimenez, U., Boulan, B., Mauconduit, F., Taurel, F., Leclercq, M., Denarier, É., Brocard, J., Gory‐Fauré, S., Andrieux, A., Lahrech, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10544-2 · Cited by 27 · see citing works
Weber‐Stadlbauer, U., Weber, E., Langhans, W., & Meyer, U. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001223 · Cited by 27 · see citing works
Hafizi, S., Silva, T. M. S., Meyer, J. H., Michael Kiang, A., Houle, S., Remington, G. J., Prce, I., Wilson, A. A., Rusjan, P., Sailasuta, N., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0061-5 · Cited by 25 · see citing works
Sharma, S., & Shukla, S. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101784 · Cited by 25 · see citing works
Górny, M., Wnuk, A., Kamińska, A., Kamińska, K., Chwatko, G., Bilska‐Wilkosz, A., Iciek, M., Kajta, M., Rogóż, Z., & Lorenc‐Koci, E. (2019) · Molecules · doi:10.3390/molecules24234253 · Cited by 24 · see citing works
Iguchi, Y., Kosugi, S., Nishikawa, H., Lin, Z., Minabe, Y., & Toda, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114024 · Cited by 20 · see citing works
Exploring the Lean Phenotype of Glutathione-Depleted Mice: Thiol, Amino Acid and Fatty Acid Profiles
Elshorbagy, A. K., Jernerén, F., Scudamore, C. L., McMurray, F., Cater, H. L., Hough, T., Cox, R., & Refsum, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163214 · Cited by 20 · see citing works
Beeraka, N. M., Ávila-Rodriguez, M., & Aliev, G. M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02703-4 · Cited by 18 · see citing works
Santos‐Silva, T., Lopes, C. F. B., Ülgen, D. H., Guimarães, D. A., Guimarães, F. S., Alberici, L. C., Sandi, C., & Gomes, F. V. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae033 · Cited by 19 · see citing works
Evaluating negative-symptom-like behavioural changes in developmental models of schizophrenia
Moser, P. C. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.004 · Cited by 16 · see citing works
Lutgen, V., Qualmann, K. J., Resch, J. M., Kong, L., Choi, S., & Baker, D. L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2926-3 · Cited by 16 · see citing works
Dias, K. C. F., de Almeida, J. C., Vasconcelos, L. C., Patrocínio, M. L. V., Barbosa, T. M., Ximenes, N. C., Leitão, A. P. D. A., Louchard, B. O., Pimenta, A. T. Á., Pinto, F. D. C. L., et al. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13039 · Cited by 15 · see citing works
Barzilay, R., Ganz, J., Sadan, O., Ben‐Zur, T., Bren, Z., Hinden, N., Taler, M., Lev, N., Gil‐Ad, I., Weizman, A., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.10.002 · Cited by 15 · see citing works
Abdominal vagal deafferentation alters affective behaviors in rats.
Klarer, M., Weber-Stadlbauer, U., Arnold, M., Langhans, W., & Meyer, U. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.015 · Cited by 13 · see citing works
A new method for vibration-based neurophenotyping of zebrafish
Wang, J., Wang, D., Hu, G., Yang, L., Yan, D., Wang, M., Serikuly, N., Alpyshov, E. T., Amstislavskaya, T. G., Demin, K. A., et al. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.108563 · Cited by 12 · see citing works
Oxidative Stress in the Early Stage of Psychosis
Ventriglio, A., Bellomo, A., Favale, D., Bonfitto, I., Vitrani, G., Dario, D. S., Cuozzo, E., Ilaria, D. G., Pettorruso, M., Perna, G., et al. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666210701105839 · Cited by 11 · see citing works
Lopes-Rocha, A. C., Bezerra, T. O., Zanotto, R., Nascimento, I. L., Rodrigues, A., & Salum, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.924955 · Cited by 11 · see citing works
Loganathan, S., Menegaz, D., Delling, J. P., Eder, M., & Deussing, J. M. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03140-2 · Cited by 10 · see citing works
Glutathione Therapy in Diseases: Challenges and Potential Solutions for Therapeutic Advancement
Dehkordi, H. T., & Ghasemi, S. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230818142831 · Cited by 10 · see citing works
Xu, Y., Yang, Y., Shi, Y., Li, B., Xie, Y., & Le, G. (2024) · npj Science of Food · doi:10.1038/s41538-024-00348-w · Cited by 8 · see citing works
Role of Oxidative Stress in Pathophysiological Progression of Schizophrenia
Bhatt, S., Upadhyay, T., Patil, C., Pai, K. S. R., Chellappan, D. K., & Dua, K. (2022) · Current Psychiatry Research and Reviews · doi:10.2174/2666082218666220822154558 · Cited by 8 · see citing works
Bertholet, L., Meunier, C., Preissmann, D., & Schenk, F. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.12.039 · Cited by 8 · see citing works
MEGA-PRESS and PRESS measure oxidation of glutathione in a phantom
Brix, M. K., Dwyer, G. E., Craven, A. R., Grüner, R., Noeske, R., & Ersland, L. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2019.03.020 · Cited by 8 · see citing works
Hess, E. M., Kassel, S. N., Simandl, G. J., Raddatz, N. J., Maunze, B., Hurley, M. M., Grzybowski, M. N., Klotz, J., Geurts, A. M., Liu, Q.-S., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1525-22.2023 · Cited by 8 · see citing works
Rodent models for mood disorders – understanding molecular changes by investigating social behavior
Reinhardt, P. R., Theis, C. D. C., Juckel, G., & Freund, N. (2023) · Biological Chemistry · doi:10.1515/hsz-2023-0190 · Cited by 7 · see citing works
Dysregulation of Glutathione Synthesis in Psychiatric Disorders
Lorenc-Koci, E. (2015) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_14 · Cited by 8 · see citing works
Preissmann, D., Depré, M., Schenk, F., & Gisquet-Verrier, P. (2016) · Brain Research · doi:10.1016/j.brainres.2016.07.042 · Cited by 6 · see citing works
Khavari, B., Barnett, M. M., Mahmoudi, E., Geaghan, M. P., Graham, A., & Cairns, M. J. (2024) · Life · doi:10.3390/life14050562 · Cited by 4 · see citing works
Blossom, S. J., Melnyk, S. B., & Simmen, F. A. (2019) · Environmental Science Processes & Impacts · doi:10.1039/c9em00514e · Cited by 4 · see citing works
Zingerone neuroprotective effects in a rat model of manic-like behavior induced by ketamine
Maleki, M., Moosavi, M., Zeidooni, L., Azadnasab, R., & Khodayar, M. J. (2023) · Learning and Motivation · doi:10.1016/j.lmot.2023.101934 · Cited by 3 · see citing works
Fathy, H., Bayoumy, H. A. H., Mawella, S. M. A., Gomaa, M. A., & Al-Hanafi, H. (2015) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000471347.83522.d8 · Cited by 2 · see citing works
Flutamide Alters Markers of Inflammation and Oxidative stress in Experimental Model of Autism
Mirza, R., Sharma, P. C., Kulkarni, G. T., & Sharma, B. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00833 · Cited by 2 · see citing works
Schmerder, K., & Freund, N. (2022) · Neuromethods · doi:10.1007/978-1-0716-2748-8_13 · Cited by 2 · see citing works
Raffa, M., Youssef, I. B. H., Othman, L. B., Fendri, C., & Mechri, A. (2021) · L Encéphale · doi:10.1016/j.encep.2020.01.010 · Cited by 2 · see citing works
Xu, Y., Yang, Y., Jiang, Y., Li, B., Xie, Y., Shi, Y., & Le, G. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116858 · Cited by 1 · see citing works
Oxidative Stress and Neuropsychiatric Disorders in the Life Spectrum
Nunomura, A., Tamaoki, T., Motohashi, N., Lee, H., Zhu, X., & Perry, G. L. (2016) · CRC Press eBooks · doi:10.1201/b20228-16 · Cited by 1 · see citing works
Oxidative Stress in Schizophrenia: Relation to Neurochemical Pathogenetic Hypotheses
Burbaeva, G. S., Prokhorova, T. A., Savushkina, O. K., Терешкина, Е. Б., Vorobyeva, E. A., & Бокша, И. С. (2024) · Psikhiatriya · doi:10.30629/2618-6667-2023-21-6-85-99 · Cited by 1 · see citing works
Acetaminophen Associated Neurotoxicity and its Relevance to Neurodevelopmental Disorders
Kim, S.-H. (2017) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1 · see citing works
Santos‐Silva, T., Lopes, C. F. B., Ülgen, D. H., Guimarães, D. A., Guimarães, F. S., Alberici, L. C., Sandi, C., & Gomes, F. V. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.28.568850 · Cited by 1 · see citing works
Estrés Oxidativo y Esquizofrenia
Prados, A. B. (2014) · doi:10.14201/gredos.124073
Glutamate-based preclinical and clinical dysfunction and treatment in bipolar disorder
Decker, A., Bacalzo, B., & Niciu, M. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821398-8.00020-5
Santos‐Silva, T. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2023.tde-10112023-160657
Mirza, R., Sharma, P. C., Kulkarni, G. T., & Sharma, B. (2024) · Indian Journal of Physiology and Pharmacology · doi:10.25259/ijpp_408_2022
Bipolar Disorder: Current Knowledge and Future Priorities
Nestler, E. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-31497-0_3
- Authors
- Kulak, A., Cuenod, M., & Do, K. Q.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Kulak, Anita
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 226
- Issue
- 2
- Pages
- 563-570
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W1979121076
- Cited by
- 90
- References
- 92
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 6 · 2023: 7 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 10 · 2018: 4 · 2017: 4 · 2016: 9 · 2015: 10 · 2014: 8 · 2013: 8 · 2012: 5
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioural Brain Research (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- glutathione deficiency, gamma-glutamylcysteine synthetase, redox dysregulation, schizophrenia, bipolar disorder, hyperlocomotion, prepulse inhibition, sensory gating, amphetamine response, social behavior, spatial working memory, latent inhibition, behavioral phenotyping
- MeSH terms
- Animals, Behavior, Animal, Bipolar Disorder, Disease Models, Animal, Glutamate-Cysteine Ligase, Glutathione, Humans, Male, Mice, Inbred C57BL, Phenotype, Schizophrenia, Schizophrenic Psychology, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review